Literature DB >> 3719588

Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.

D A Vorobiof, R Sarli, G Falkson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3719588

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

1.  Phase II trial of carboplatin in patients with advanced melanoma.

Authors:  E S Casper; D Bajorin
Journal:  Invest New Drugs       Date:  1990-05       Impact factor: 3.850

Review 2.  Melanoma immunotherapy dominates the field.

Authors:  Panagiotis Diamantopoulos; Helen Gogas
Journal:  Ann Transl Med       Date:  2016-07

3.  Carboplatinum and cytosine arabinoside in patients with disseminated malignant melanoma. A phase II study.

Authors:  B Jeremic; L Djuric; L Mijatovic
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

4.  Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study.

Authors:  U Ringborg; C M Rudenstam; J Hansson; L Hafström; B Stenstam; H Strander
Journal:  Med Oncol Tumor Pharmacother       Date:  1989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.